1. Medtech Insight
  2. >>Business

News We’re Watching: Activist Investor Causes Kerfuffle At Nevro, Lifespin Launches Antibiotic Dx, And More

 
• By Reed Miller

Medtech Insight's News We're Watching highlights medtech industry news developments that you may have missed over the last few weeks. Last week, EndoQuest closed a $42m round to support its endoluminal surgery system, Intuitive Ventures closed a $150m round, Noah Surgical announced the first biopsy procedures with its Galaxy technology in Asia, the FDA cleared Smileyscope's VR system to reduce needle anxiety, and Guardant will collaborate with Cancer Research UK.

Industry News We're Watching
• Source: Shutterstock

Engaged Capital wants Nevro to focus on achieving profitability instead of acquisitions, according to a report from Bloomberg Law.

In a new 13D filing with the US Securities and Exchange Commission, the Southern California-based activist investor firm disclosed that it now owns about 6% of Nevro stock

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Business

More from Medtech Insight